Table of Contents

July 01, 2008; Volume 75, Issue 7
  • From the Editor

      • A drug, a concept, and a clinical trial on trial

        Brian F. Mandell, MD, PhD
        • Cleveland Clinic Journal of Medicine July 2008, 75 (7) 470;
        • The ENHANCE trial, evaluating the addition of a second hypocholesterolemic drug (ezetimibe) to a statin using two surrogate end points in a relatively small number of patients, hit the national news when the two surrogates didn’t match up.

  • The Clinical Picture

      • Generalized pruritus after a beach vacation

        Sergio Vañó-Galván, MD and Paula Moreno-Martin, MD
        • Cleveland Clinic Journal of Medicine July 2008, 75 (7) 474-478;
        • A 25-year-old man presents with a 2-month history of generalized itching that began 5 weeks after a trip to Brazil, during which he had sexual relations without protection. What is the most likely diagnosis?

  • Commentary

      • Interpreting the Enhance Trial

        Michael H. Davidson, MD
        • Cleveland Clinic Journal of Medicine July 2008, 75 (7) 479-491;
        • The impact of the ENHANCE trial reveals more about the political climate than it does about the effects of ezetimibe on the progression of atherosclerosis.

  • Editorial

  • Review

      • Bacterial conjunctivitis: A review for internists

        Ahmad B. Tarabishy, MD and Bennie H. Jeng, MD
        • Cleveland Clinic Journal of Medicine July 2008, 75 (7) 507-512;
        • It is critical to differentiate bacterial conjunctivitis from other types of conjunctivitis and more serious vision-threatening conditions so that patients can be appropriately treated and, if necessary, referred to an ophthalmologist.

      • Perioperative beta-blockers in noncardiac surgery: Evolution of the evidence

        Brian Harte, MD and Amir K. Jaffer, MD
        • Cleveland Clinic Journal of Medicine July 2008, 75 (7) 513-519;
        • The pendulum of opinion is swinging away from routinely recommending beta-blockers to prevent cardiac events in surgical patients. We will probably be using them more selectively than in the past.

      • TOC Icon

        Blood smear analysis in babesiosis, ehrlichiosis, relapsing fever, malaria, and Chagas disease

        Steve M. Blevins, MD, Ronald A. Greenfield, MD and Michael S. Bronze, MD
        • Cleveland Clinic Journal of Medicine July 2008, 75 (7) 521-530;
        • Blood smear analysis should be performed in patients with persistent or recurring fever, those who have traveled to the developing world, or those who have a history of tick exposure, especially if accompanied by hemolytic anemia, thrombocytopenia, or hepatosplenomegaly.

      • From the Children’s Oncology Group

        Allen Liles, MD, Julie Blatt, MD, David Morris, MD, Richard Wardrop III, MD, Anjali Sharma, MD, Aimee Sznewajs, MS, PNP and Robert Goldsby, MD
        • Cleveland Clinic Journal of Medicine July 2008, 75 (7) 531-539;
        • Children who undergo radiotherapy, chemotherapy, or surgery for cancer face a risk of complications later in life, including pulmonary fibrosis and pneumonitis. They need systematic, lifelong surveillance.

  • The Clinical Picture

      • Dyspnea, arthralgias, and muscle weakness

        Rachel M. Taliercio, DO and Jeffrey Chapman, MD
        • Cleveland Clinic Journal of Medicine July 2008, 75 (7) 540-542;
        • A computed tomographic scan shows ground-glass opacities in the lower lobes of both lungs. What is the most likely cause of this patient’s symptoms and radiographic findings?

  • Departments